Carboplatin-paclitaxel compared to Carboplatin-Paclitaxel-Bevacizumab in advanced or recurrent endometrial cancer: MITO END-2 - A randomized phase II trial
| Autor: | Lorusso, D., Ferrandina, G., Colombo, N., Pignata, S., Pietragalla, A., Sonetto, C., Pisano, C., Lapresa, M.T., Savarese, A., Tagliaferri, P., Lombardi, D., Cinieri, S., Breda, E., Sabatucci, I., Sabbatini, R., Conte, C., Cecere, S.C., Maltese, G., Scambia, G. |
|---|---|
| Zdroj: | In Gynecologic Oncology December 2019 155(3):406-412 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect